Advertisement

Coming of Age and Refusing to Eat: Overcoming Treatment Nonadherence for Adolescents with Anorexia Nervosa

  • Victor FornariEmail author
  • Ida Dancyger
Chapter

Abstract

Acceptance of the diagnosis of anorexia nervosa during adolescence and the subsequent treatment of this serious disorder, as well as adherence to the therapeutic recommendations, present significant clinical challenges. This is especially true as the core symptoms of the illness are in direct conflict with the medically necessary goals of gaining weight and normalizing eating behaviors. The path to recovery is in strong opposition to the patient’s obsessional thoughts and restrictive food-related behaviors. This remains a critical matter, given the high mortality rate. Various approaches to engage the adolescent will be discussed in this chapter. We examine the five factors (social and economic factors, healthcare team and system-related factors, condition-related factors, therapy-related factors, and patient-related factors) contributing to nonadherence and offer strategies from our clinical practice and expertise, the literature, as well as some research findings.

Keywords

Treatment nonadherence Anorexia nervosa Strategies to enhance adherence to treatment 

References

  1. 1.
    Woodside DB, Carter JC, Blackmore E. Predictors of premature termination of inpatient treatment for anorexia nervosa. Am J Psychiatry. 2004;161(12):2277–82.CrossRefGoogle Scholar
  2. 2.
    Papodopoulos FC, Ekbom A, Brandt L, Ekselius L. Excess mortality, causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry. 2009;194(1):10–7.CrossRefGoogle Scholar
  3. 3.
    Crow SJ, Peterson CB, Swanson SA, Raymond NC, Specker S, Eckert ED, Mitchell JE. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry. 2009;166(12):1342–6.CrossRefGoogle Scholar
  4. 4.
    Fornari V, Kaplan M, Sandberg D, Matthews M, Katz J. The relationship between depression and anxiety disorders in anorexia nervosa and bulimia nervosa. Int J Eat Disord. 1992;12(1):21–9.CrossRefGoogle Scholar
  5. 5.
    World Health Organization (WHO). Adherence to long-term therapies: evidence for action. 2003.; http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed 2/5/2018.
  6. 6.
    American Psychiatric Association. Practice guideline for the treatment of patients with eating disorders, 3rd edition. Am J Psychiatry. 2006;163(suppl):1–54.Google Scholar
  7. 7.
    Yaeger J, Devlin MJ, Halmi KA, Herzog DB, Mitchell JE, Powers P, Zerbe KJ. Guideline watch (August 2012): practice guideline for the treatment of patients with eating disorders, 3rd edition. APA Executive Committee on Practice Guidelines. APA.Google Scholar
  8. 8.
    Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Golden NH, Malhotra AK. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. J Child Adolesc Psychopharmacol. 2011;21(3):207–12.CrossRefGoogle Scholar
  9. 9.
    Royal College of Psychiatrists. MARSIPAN: management of really sick patients with anorexia nervosa. 2nd ed; 2014. http://www.rcpsych.ac.uk/publications/collegereports.aspx.
  10. 10.
    Alanon Pardo MDM, Ferrit Martin M, Calleja Hernandez MA, Morillas Marquez F. Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders. Eur J Clin Pharmacol. 2017;73(10):1305–13.CrossRefGoogle Scholar
  11. 11.
    Bruce KR, Steiger H. Treatment implications of Axis-II comorbidity in eating disorders. Eat Disord. 2005;13(1):93–108.CrossRefGoogle Scholar
  12. 12.
    Bodell LP, Keel PK. Current treatment of anorexia nervosa: efficacy, safety and adherence. Psychol Res Behav Manag. 2010;3:91–108.CrossRefGoogle Scholar
  13. 13.
    Eisler I, Simic M, Russell GF, Aare C. A randomized controlled treatment trial of two forms of family therapy in adolescent anorexia nervosa: a five-year follow-up. J Child Psychol Psychiatry. 2007;48(6):552–260.CrossRefGoogle Scholar
  14. 14.
    Halmi KA. Perplexities of treatment resistance in eating disorders. BioMed Cent Psychiatry. 2013;13:292.CrossRefGoogle Scholar
  15. 15.
    Steiner H, Mazer D, Litt IF. Compliance and outcome in anorexia nervosa. West J Med. 1990;153(2):133–9.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Towell DB, Woodford S, Reid S, Rooney B, Towell A. Compliance and outcome in treatment-resistant anorexia and bulimia: a retrospective study. Br J Clin Psychol. 2001;40(Pt 2):189–95.CrossRefGoogle Scholar
  17. 17.
    Fornari V, Dancyger U, Schneider M, Fisher M, Goodman B, McCall A. Parental medical in the treatment of adolescents with anorexia nervosa. Int J Eat Disord. 2001;29(3):358–62.CrossRefGoogle Scholar
  18. 18.
    NICE guidance and guidelines. Eating disorders: recognition and treatment. May 2017; National Institute for Health and Care Excellence.Google Scholar
  19. 19.
    Wilson GT, Shafran R. Eating disorders guidelines from NICE. Lancet. 2005;365(9453):79–81.CrossRefGoogle Scholar
  20. 20.
    Lock J, LeGrange D. Treatment manual for anorexia nervosa: a family-based approach. New York: The Guilford Press; 2015.Google Scholar
  21. 21.
    Dalle Grave R, Calugi S, El Ghoch M, Conti M, Fairburn CG. Inpatient cognitive behavior therapy for adolescents with anorexia nervosa: immediate and longer-term effects. Front Psychiatry. 2014;5(14):12.Google Scholar
  22. 22.
    Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998;155(4):548–51.CrossRefGoogle Scholar
  23. 23.
    Biederman J, Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985;5(1):10–6.CrossRefGoogle Scholar
  24. 24.
    Moskowitz LJ, Ku B, Shadianloo S, Fornari VM. Psychopharmacology in the treatment of eating disorders. Adolesc Med (AMSTAR). 2018;029:384–403.Google Scholar
  25. 25.
    Wade TD, Frayne A, Edward SA, Robertson T, Gilchrist P. Motivational change in an inpatient anorexia nervosa population and implications for treatment. Aust N Z J Psychiatry. 2009;43(3):235–43.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellHempsteadUSA
  2. 2.Division of Child and Adolescent Psychiatry, Department of PsychiatryNorth Shore University Hospital and The Long Island Jewish Medical Center (Including The Zucker Hillside Hospital and Cohen Children’s Medical Center)Glen OaksUSA

Personalised recommendations